The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
about
Self management interventions including action plans for exacerbations versus usual care in people with chronic obstructive pulmonary diseaseSelf management for patients with chronic obstructive pulmonary diseaseAsthma-COPD overlap syndrome (ACOS): A diagnostic challengeIndirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United StatesHealth and social impacts of COPD and the problem of under-diagnosisComparative effectiveness research in chronic obstructive pulmonary diseaseThe association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysisTotal particulate matter concentration skews cigarette smoke's gene expression profilePulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant?Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood.Computerised Analysis of Telemonitored Respiratory Sounds for Predicting Acute Exacerbations of COPD.Predicting chronic obstructive pulmonary disease hospitalizations based on concurrent influenza activity"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD.An analysis of the economic and patient outcome impact of an integrated COPD service in east London.The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients.Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data.Exacerbations in patients with chronic obstructive pulmonary disease receiving physical therapy: a cohort-nested randomised controlled trial.Association of serum interleukin-27 with the exacerbation of chronic obstructive pulmonary diseaseManagement of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009.Integrating COPD into Patient-Centered Hospital Readmissions Reduction ProgramsSeasonality, ambient temperatures and hospitalizations for acute exacerbation of COPD: a population-based study in a metropolitan areaA Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Thiazolidinediones are associated with a reduced risk of COPD exacerbationsUse of predictive algorithms in-home monitoring of chronic obstructive pulmonary disease and asthma: A systematic review.Does Telehealth Monitoring Identify Exacerbations of Chronic Obstructive Pulmonary Disease and Reduce Hospitalisations? An Analysis of System Data.COPD exacerbation frequency and its association with health care resource utilization and costs.Early assisted discharge with generic community nursing for chronic obstructive pulmonary disease exacerbations: results of a randomised controlled trial.COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare membersImpacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database.Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.Predictors for mortality due to acute exacerbation of COPD in primary care: protocol for the derivation of a clinical prediction rule.Costs of chronic obstructive pulmonary disease in urban areas of China: a cross-sectional study in four citiesExacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.How do general practitioners implement decision-making regarding COPD patients with exacerbations? An international focus group study.Barriers to and enablers of physical activity in patients with COPD following a hospital admission: a qualitative study.Current situation of asthma-COPD overlap syndrome (ACOS) in Chinese patients older than 40 years with airflow limitation: rationale and design for a multicenter, cross-sectional trial (study protocol).Triple therapy for the management of COPD: a review.Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues.Home telemonitoring effectiveness in COPD: a systematic review.
P2860
Q24188309-DBE84360-CC44-4835-9343-B1A728A9F8F2Q24197903-BF57A3B2-8CBB-4E66-AE20-3B8CD0A95F19Q26785749-3F020727-EC4C-40EE-B140-7A76BC394E81Q26858945-479BF8CC-29D0-41A7-B640-CEDBE64D1449Q26864108-1F6FDE09-D42A-4339-879C-3AD55B4AB2B6Q26864606-2BBB341A-0B23-4031-94F9-99CECC402E94Q28070325-78FED199-C306-43A3-B6D4-1DA3A05F6F9EQ28586338-ACE3CAE9-282D-424D-AF11-6BCB53F9B736Q28596796-1908CD7D-6E9A-4014-9376-BC69A7637A25Q30371420-5FDA7F7B-3A59-4B3D-942D-02497944B3D3Q30398378-9DD82AC1-CCA0-46E2-AC85-C5959FD98319Q30432654-7D0B91D0-8DD9-49EA-98C1-2B4DE04FED86Q33693227-87B81D9B-255B-4AA8-B480-782F6F52C8F3Q33806792-FAF6A7F3-7E9C-47EF-8E18-ECB18FB151CCQ33817770-E07561E1-9E7C-4A52-86AD-2489A3C90A9DQ33827577-94FEB620-4954-4E05-8110-FED9629F4474Q33938723-8B19E343-49DD-4D52-8F1D-8B128FF9308AQ34297424-3D339F4D-44E7-48F0-81E3-91405B935830Q35225129-815B121C-46A4-4817-9857-B9350FC61380Q35508638-B256B68A-1FB3-4B95-8777-D885D8742577Q35541274-5B417108-CE42-4608-AE50-0C0E13136343Q35605826-47D4EEF5-A225-4937-BD6B-F9CA6371161EQ35838507-E0AAE25F-EEB5-49C0-91D2-1B1179775487Q35954327-922D8CD6-E5B2-43D7-B5A4-2F4056397016Q35995056-BFE580D0-4F75-4FB3-BB71-9B3A3B8C84BEQ36318981-3987DB5A-AE2B-4257-A9C8-758D202D372DQ36352161-503F9903-BE88-4CBE-9163-524630A40204Q36370339-C31AA414-2E48-44E2-AD44-F6C26622CC9FQ36473543-19348D5B-B87A-4EE1-B2F4-8E2F0E129269Q36826833-640DB3FA-08C8-4FD3-8DAC-161BBEE6985FQ37158368-CF704B37-9621-4761-9E8B-CDEFD288D270Q37353886-658B1FCD-73C8-44EA-834C-A59279DB5D67Q37365503-8525BB2F-1E59-4FB9-9FC8-6C93E23DA2B9Q37396561-BC592874-4E20-46B7-8800-F525FCF5AF8BQ37496448-6066149F-0130-4BCB-9C83-6DD08E1EAF92Q37525031-3E22A469-F7EA-4F3E-9A12-B16190DC58F9Q37581257-5B06458F-04F4-4944-B427-AD801E2EE15DQ37868010-8EBF02F1-1506-4CCF-BAB3-8ADE5A44BC30Q37992679-848BB1D1-49D3-4862-BFBA-BCE61EC4FB56Q38182701-8BD19932-B8C3-4AA8-8A82-18EF98FD5BD3
P2860
The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The economic impact of exacerb ...... erbation definition: a review.
@en
The economic impact of exacerb ...... erbation definition: a review.
@nl
type
label
The economic impact of exacerb ...... erbation definition: a review.
@en
The economic impact of exacerb ...... erbation definition: a review.
@nl
prefLabel
The economic impact of exacerb ...... erbation definition: a review.
@en
The economic impact of exacerb ...... erbation definition: a review.
@nl
P2093
P1476
The economic impact of exacerb ...... erbation definition: a review.
@en
P2093
Andrine R Swensen
Edmond L Toy
Elizabeth L Stanley
Kevin F Gallagher
Mei Sheng Duh
P304
P356
10.3109/15412555.2010.481697
P407
P577
2010-06-01T00:00:00Z